Código QR (código de barras bidimensional)

Sodium Zirconium Cyclosilicate Duration and Hyperkalemia-Related Healthcare Encounters in Patients with Heart Failure and Cardio/Renal Dysfunction: The GALVANIZE Outcome Study

Abstract Background and Objective Patients with heart failure or cardio/renal dysfunction (chronic kidney disease, end-stage kidney disease, or heart failure) are at increased risk of hyperkalemia. Sodium zirconium cyclosilicate (SZC) treats hyperkalemia, but the impact of SZC treatment duration on...

תיאור מלא

שמור ב:
Principais autores: Abiy Agiro, Fan Mu, Erin E. Cook, Ali Greatsinger, Jingyi Chen, Manasvi Sundar, Angela Zhao, Ellen Colman, Arun Malhotra
פורמט: Artigo
שפה:Inglês
יצא לאור: Adis, Springer Healthcare 2025-10-01
סדרה:Drugs - Real World Outcomes
גישה מקוונת:https://doi.org/10.1007/s40801-025-00525-7
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים